Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection | Zendy

Zeinab Mehrabi | Zendy; Maryam Salimi | Zendy; Kianoush Niknam | Zendy; Farzaneh Mohammadi | Zendy; Hesan Jelodari Mamaghani | Zendy; Mohammad Reza Sasani | Zendy; Mohammad Javad Ashraf | Zendy; Amirhossein Salimi | Zendy; Mohammad Hassan Zahedroozegar | Zendy; Zohreh Erfani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection

Author(s) -

Zeinab Mehrabi,

Maryam Salimi,

Kianoush Niknam,

Farzaneh Mohammadi,

Hesan Jelodari Mamaghani,

Mohammad Reza Sasani,

Mohammad Javad Ashraf,

Amirhossein Salimi,

Mohammad Hassan Zahedroozegar,

Zohreh Erfani

Publication year - 2021

Publication title -

case reports in ophthalmological medicine

Language(s) - English

Resource type - Journals

eISSN - 2090-6722

pISSN - 2090-6730

DOI - 10.1155/2021/9745701

Subject(s) - medicine , mucormycosis , covid-19 , antifungal , corticosteroid , opportunistic infection , presentation (obstetrics) , intensive care medicine , pandemic , case presentation , pediatrics , dermatology , surgery , immunology , human immunodeficiency virus (hiv) , disease , viral disease , infectious disease (medical specialty)

Background Mucormycosis is a rare and invasive fungal infection, affecting almost exclusively immunocompromised individuals. Immunosuppressive effects of corticosteroids which are widely prescribed in COVID-19 patients might be a predisposing factor for opportunistic infections even though the other factors should also be considered. Case Presentation . A middle-aged man without any significant past medical history was admitted to the hospital due to a severe COVID-19 infection. He received a high dose of corticosteroids as a part of the treatment. Five days after discharge, he presents with a headache and fever. Eventually, orbital mucormycosis was diagnosed for him and he was treated with antifungal medications.Conclusion Opportunistic infections should be considered during the current pandemic of COVID-19, during which corticosteroids are widely prescribed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research